Ladenburg Thalmann Downgrades CryoLife (CRY) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Six dead in 'stampede-like' incident at India temple, ANI says
- US considers new sanctions on Brazilian judge, FT reports
CryoLife Reports First Quarter 2016 Financial Results
April 27, 2016 5:34 PM EDTATLANTA, April 27, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the first quarter of 2016.Â
Recent Highlights:
First Quarter Revenue Increased 27 Percent Year-over-Year to $43.0 Million; Pro Forma Revenues Increased Nine Percent Year-over-Year Strengthened Focus on Cardiac Surgery Technologies and Enhanced Growth Potential Through Strategic Initiatives, including: Acquisition of On-X® Life Technologies (On-X) Sale of HeRO® Graft Product Line Sale of ProCol®... More